乳腺浸润性微乳头状癌转移机制的研究进展

doi:10.11904/j.issn.1002-3070.2022.03.014

Abstract

Abstract: Invasive micropapillary carcinoma(IMPC)of breast is a rare histopathological variant of breast cancer,accounting for approximately 3%-8% of all breast cancer.Compared with invasive ductal carcinoma of no special type(IDC-NST),although the incidence of IMPC is low,IMPC shows a tendency of lymphatic invasion and lymph node metastasis.Therefore,understanding its metastasis mechanism is particularly important for intervening in the clinical diagnosis and treatment process.This article aims to review the metastatic mechanism of IMPC and related to clinical evidence,so as to provide new ideas for the treatment of IMPC.

Key words: Breast cancer, Invasive micropapillary carcinoma, Mechanism of metastasis

CLC Number:

R730.5

LIU Wanying, PANG Da. Research progress on the mechanism of metastasis in invasive micropapillary carcinoma of the breast[J]. Journal of Practical Oncology, 2022, 36(3): 268-272.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2022.03.014

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2022/V36/I3/268

References

1 Wang R,Li N,Wang XJ,et al.Differences in the clinicopathological characteristics of pure and mixed invasive micropapillary breast carcinomas from eastern China[J].Ann Transl Med,2021,9(5):412.
2 Fisher ER,Palekar AS,Redmond C,et al.Pathologic findings from the national surgical adjuvant breast project(protocol no.4).VI.invasive papillary cancer[J].Am J Clin Pathol,1980,73(3):313-322.
3 Siriaunkgul S,Tavassoli FA.Invasive micropapillary carcinoma of the breast[J].Mod Pathol,1993,6(6):660-662.
4 Ye F,Yu P,Li N,et al.Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast:a meta-analysis of PSM studies[J].Breast,2020,51:11-20.
5 Fu L,Ikuo M,Fu XY,et al.Relationship between biologic behavior and morphologic features of invasive micropapillary carcinoma of the breast[J].Zhonghua Bing Li Xue Za Zhi,2004,33(1):21-25.
6 Yang YL,Liu BB,Zhang X,et al.Invasive micropapillary carcinoma of the breast:an update[J].Arch Pathol Lab Med,2016,140(8):799-805.
7 王月辰,汤璐,邢华,等.乳腺浸润性微乳头状癌临床病理及诊治的研究进展[J].中国普外基础与临床杂志,2019,26(5):636-640.
8 Guo X,Chen L,Lang R,et al.Invasive micropapillary carcinoma of the breast:association of pathologic features with lymph node metastasis[J].Am J Clin Pathol,2006,126(5):740-746.
9 Acs G,Esposito NN,Rakosy Z,et al.Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma[J].Am J Surg Pathol,2010,34(11):1637.
10 Shi WB,Yang LJ,Hu X,et al.Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma:a population-based study from China[J].PLoS One,2014,9(6):e101390.
11 Marchiò C,Iravani M,Natrajan R,et al.Mixed micropapillary-ductal carcinomas of the breast:a genomic and immunohistochemical analysis of morphologically distinct components[J].J Pathol,2009,218(3):301-315.
12 Deman F,Punie K,Laenen A,et al.Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes[J].Breast Cancer Res Treat,2020,184(3):985-998.
13 Zhao C,Thompson BJ,Chen K,et al.The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44[J].Oncotarget,2019,10(61):6561-6576.
14 徐锦屏,沈卫达,李冰,等.HSPA5和CD44v6在乳腺癌组织中的表达及其诊断价值[J].海南医学,2019,30(4):424-426.
15 Umeda T,Ishida M,Murata S,et al.Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast:comparison with a concurrent conventional invasive carcinoma of no special type component[J].Breast Cancer,2016,23(6):869-875.
16 Badyal RK,Bal A,Das A,et al.Invasive micropapillary carcinoma of the breast:immunophenotypic analysis and role of cell adhesion molecules(CD44 and E-Cadherin)in nodal metastasis[J].Appl Immunohistochem Mol Morphol,2016,24(3):151-158.
17 Gamba CO,Rodrigues MA,Gomes DA,et al.The relationship between E-Cadherin and its transcriptional repressors in spontaneously arising canine invasive micropapillary mammary carcinoma[J].J Comp Pathol,2015,153(4):256-265.
18 Huang L,Ji H,Yin L,et al.High expression of plakoglobin promotes metastasis in invasive micropapillary carcinoma of the breast via tumor cluster formation[J].J Cancer,2019,10(12):2800-2810.
19 Wang XX,Liu BB,Wu X,et al.Loss of leucine zipper putative tumor suppressor 1(LZTS1)expression contributes to lymph node metastasis of breast invasive micropapillary carcinoma[J].Pathol Oncol Res,2015,21(4):1021-1026.
20 Zhang C,Wang L,Jin C,et al.Long non-coding RNA Lnc-LALC facilitates colorectal cancer liver metastasis via epigenetically silencing LZTS1[J].Cell Death Dis,2021,12(2):224.
21 Hou X,Niu Z,Liu L,et al.miR-1207-5p regulates the sensitivity of triple-negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression[J].Oncol Lett,2019,17(1):990-998.
22 Lin B,Du L,Li H,et al.Tumor-infiltrating lymphocytes:warriors fight against tumors powerfully[J].Biomed Pharmacother,2020,132:110873.
23 袁静萍,袁修学,阎红琳.肿瘤浸润淋巴细胞在乳腺癌肿瘤微环境中的角色[J].临床与实验病理学杂志,2018,34(12):1356-1359.
24 沈浩元,邓春燕,戴一菲,等.Fas、FasL蛋白与乳腺癌相关性的临床研究[J].中国现代普通外科进展,2017,20(12):948-951.
25 Lin EY,Pollard J W.Role of infiltrated leucocytes in tumour growth and spread[J].Br J Cancer,2004,90(11):2053-2058.
26 Guo X,Fan Y,Lang R,et al.Tumor infiltrating lymphocytes differ in invasive micropapillary carcinoma and medullary carcinoma of breast[J].Mod Pathol,2008,21(9):1101-1107.
27 Li S,Yang C,Zhai L,et al.Deep sequencing reveals small RNA characterization of invasive micropapillary carcinomas of the breast[J].Breast Cancer Res Treat,2012,136(1):77-87.
28 Marchiò C,Iravani M,Natrajan R,et al.Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast[J].J Pathol,2008,215(4):398-410.
29 Meng F,Liu B,Xie G,et al.Amplification and overexpression of PSCA at 8q24 in invasive micropapillary carcinoma of breast[J].Breast Cancer Res Treat,2017,166(2):383-392.
30 Dieci MV,Smutná V,Scott V,et al.Whole exome sequencing of rare aggressive breast cancer histologies[J].Breast Cancer Res Treat,2016,156(1):21-32.

[1]	YANG Zihan, XU Shouping, PANG Da. Characteristics of breast cancer metastases to outer triangle tissue and its influencing factors [J]. Journal of Practical Oncology, 2022, 36(3): 226-232.
[2]	HE Weidan, LI Zhigao. FSIP1 promotes migration and invasion of breast cancer cells and leads to poor prognosis of patients [J]. Journal of Practical Oncology, 2022, 36(3): 233-238.
[3]	LIU Xinxin, YAO Xinhui, SUN Yuefeng, MIU Meiqi, CHEN Jing. Research progress in the role of chemokine CCL20 in breast cancer microenvironment [J]. Journal of Practical Oncology, 2022, 36(3): 250-254.
[4]	YANG Shuya, LIU Wenhui, LUO Naixiang. Research status and application prospect of UCA1 in breast cancer [J]. Journal of Practical Oncology, 2022, 36(3): 263-267.
[5]	SUN Yuanyuan, ZHANG Ningzhi, CAO Mengru. The mechanism and treatment progress of breast cancer lung metastasis [J]. Journal of Practical Oncology, 2022, 36(2): 173-177.
[6]	HOU Jianxun, WANG Hongbin. Research progress on the influence of exosomes in the integration of breast cancer diagnosis and treatment [J]. Journal of Practical Oncology, 2022, 36(2): 178-182.
[7]	CHEN He, WANG Qiucheng, CHENG Wen. The application progress of automatic breast ultrasound diagnosis system in breast cancer [J]. Journal of Practical Oncology, 2022, 36(2): 193-196.
[8]	LI Weihua, ZHANG Guangfeng, MA Lili, HE Pin, WANG Wen, LI Dingfu. Construction of a breast cancer prognostic model based on metabolism-related genes in the TCGA database [J]. Journal of Practical Oncology, 2022, 36(1): 37-43.
[9]	CAO Shiyu, JIANG Yongdong. The influence of gene expression,polygene detection and biomarkers on the prognosis of Luminal A-like breast cancer [J]. Journal of Practical Oncology, 2022, 36(1): 89-93.
[10]	LUO Bo, ZHANG Qu, ZHENG Hongmei, LIANG Xinjun, ZHOU Xiaomei, WU Xinhong. Efficacy and prognosis of SRT combined with lapatinib in the treatment of HER2-positive breast cancer brain metastasis [J]. Journal of Practical Oncology, 2021, 35(6): 523-528.
[11]	SHI Runze, LI Zhigao. Research progress of precision medical strategy for different subtypes of triple negative breast cancer [J]. Journal of Practical Oncology, 2021, 35(6): 529-533.
[12]	LI Xiang, HU Yang, ZHANG Qingyuan. Research progress of tumor mutational burden as an emerging biomarker for breast cancer immunotherapy [J]. Journal of Practical Oncology, 2021, 35(6): 568-571.
[13]	ZHOU Tianhong, GU Xiuying, YAO Fang, SONG Shuming. Analysis for screening results of breast cancer in Urumqi from 2014 to 2018 [J]. Journal of Practical Oncology, 2021, 35(5): 391-395.
[14]	MA Buhuan¹, LIU Caixia². Research progress of Jagged1 promoting the occurrence,development and distant metastasis of breast cancer [J]. Journal of Practical Oncology, 2021, 35(5): 452-457.
[15]	QIN Chao, LI Jiang, ZHENG Yadi, WANG Fei, CAO Wei, XU Yongjie, YU Yiwen, ZHAO Liang, YU Xinyang, CHEN Hongda, REN Jiansong, WANG Yong, LI Jing, LI Ni, CHEN Wanqing. Analysis of screening compliance and related factors in high-risk populations of breast cancer in Chinese cities [J]. Journal of Practical Oncology, 2021, 35(4): 291-296.

Research progress on the mechanism of metastasis in invasive micropapillary carcinoma of the breast

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments